GSK pulls plans to market anemia drug in EU and other markets, citing 'reduced opportunity'
It appears GSK’s Jesduvroq will not launch in new markets for now, with the pharma giant withdrawing its bid to market the anemia drug in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
